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Abstract
 
Aims
 
To investigate the importance of a maternal and paternal family history of Type 2 diabetes and their combined
association with plasma leptin and adiponectin levels in overweight Latino children with a family history of Type 2
diabetes (T2DM).
 
Methods
 
This cross-sectional study investigated the combined association of a maternal and paternal family history of
T2DM with leptin and adiponectin in 175 overweight Latino children (age 11.1 
 
±
 
 1.7 years). All subjects had a family
history of T2DM. Plasma adiponectin and leptin levels, body fat measured by dual-energy X-ray absorptiometry, Tanner
stage, age and insulin sensitivity were assessed.
 
Results
 
After adjustment for age, gestational diabetes, insulin sensitivity and body fat, a combined maternal and paternal
family history of T2DM was associated with higher leptin concentrations (
 
P 
 
=
 
 0.004) compared with a maternal or
paternal family history alone. This association was most pronounced at Tanner stage 1 (
 
P
 
 for interaction family
history 
 
×
 
 tanner stage 
 
=
 
 0.022). The presence of a combined maternal and paternal family history of T2DM accounted for
4% (
 
P 
 
=
 
 0.003) of the variation in leptin concentrations. No such combined association was observed for adiponectin levels.
 
Conclusions
 
Maternal and paternal family history of T2DM may have an additive impact on leptin, but not on
adiponectin levels independent of adiposity and insulin sensitivity in overweight Latino children. This may contribute to
a further clinically relevant deterioration of metabolic health in this population.
Diabet. Med. 25, 1043–1048 (2008)
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Introduction
 
Adipose tissue has characteristics similar to endocrine organs.
It secretes hormones affecting glucose metabolism and insulin
sensitivity such as leptin and adiponectin [1]. Leptin acts to
reduce food intake and increase energy expenditure [2]. In
adults, levels of circulating leptin are directly proportional to
total fat mass [3] and are negatively associated with insulin
sensitivity [4,5]. Conversely, adiponectin decreases insulin
resistance by stimulating glucose uptake and fatty acid oxida-
tion in skeletal muscle [6,7]. We recently showed that leptin
and adiponectin were independently associated with insulin
sensitivity in overweight Hispanic adolescents [8].
Leptin levels increase before puberty and trigger the onset of
puberty in humans [9]. In children approaching puberty, leptin
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levels are closely related to luteinizing hormone and follicle-
stimulating hormone, and leptin is therefore an important
facilitator in the early phases of human puberty [9,10].
In adults, a family history of Type 2 diabetes (T2DM) is
associated with higher concentrations of circulating leptin
[11–13] and lower concentrations of circulating adiponectin
[14–18]. In most studies, this association was independent of
adiposity. In offspring of parents with T2DM, future risk of
diabetes is higher in those with maternal history compared
with those with paternal history [19]. However, to our know-
ledge no information is currently available on the association
of maternal vs. paternal family history of T2DM with leptin
and adiponectin levels, nor has any study addressed this
question in an adolescent population.
Therefore, the aim of the present study was to investigate
the importance of a maternal and paternal family history of
T2DM and their combined association with plasma leptin and
adiponectin levels in overweight Latino children with a family
history of T2DM. The hypothesis was that children with both
a maternal and paternal family history of T2DM have higher
leptin and lower adiponectin levels than children with a family
history of T2DM in one parent’s family, either maternal or
paternal. We also hypothesized that a maternal family history
of T2DM may be more important than a paternal family history.
 
Participants and methods
 
Study design
 
For the present study, a cross-sectional subgroup of 175 subjects
was used based on the availability of leptin and adiponectin
data measured at entry into the Study of Latino Adolescents at
Risk (SOLAR) Diabetes Project. Detailed study descriptions
have been published previously [20]. Participants were recruited
from the East and Central Los Angeles County. Participants
were included with an age of 8–13 years, a body mass index
 
≥
 
 85th percentile for age and sex according to the Centers for
Disease Control and Prevention, a Latino ancestry (all four
grandparents Latino by parental self-report) and a family history
of T2DM in at least one parent, sibling or grandparent (parental
self-report); and absence of diabetes, determined by an oral
glucose tolerance test using a dose of 1.75 g of glucose per kg body
weight (to maximum 75 g). Participants were excluded if they
were taking medications known to affect body composition,
known to have any condition which affects body composition
or fat distribution, or had had any major illness. The Institu-
tional Review Board of the University of Southern California
(USC) approved the study protocol. Written informed consent
from parents and assent from children were obtained.
 
Biochemical measures
 
For this study, data were collected over two separate clinical
visits in the first annual visit. Children were admitted to the USC
General Clinical Research Center (GCRC) at approximately
07.30 h after an overnight fast, no food or caloric beverages
after 20.00 h. A licensed paediatric healthcare provider con-
ducted a detailed medical history, including parental interview
with detailed assessment of family history of diabetes; Tanner
staging based on breast stage in girls and pubic hair stage in
boys was assessed. Children then completed a 2-h oral glucose
tolerance test on the same day. At the second clinical visit, after
an overnight fast, a frequently sampled intravenous glucose
tolerance test (FSIVGTT) was conducted and body composition
was assessed. The evening before, the children were served dinner
and an evening snack, and only water and non-caloric and
non-caffeinated beverages were permitted after 20.00 h.
The methods of the study have been previously reported in
detail elsewhere [14]. Briefly, total body fat was assessed by a
whole body scan using dual energy X-ray absorptiometry
(Hologic QDR 4500W; Hologic, Bedford, MA, USA). Central
fat distribution was measured directly by magnetic resonance
imaging at the Los Angeles County/USC Imaging Science Center.
A single-slice axial TR 400/16 view of the abdomen at the level
of the umbilicus was analysed for cross-sectional area of adipose
tissue using a General Electric 1.5 Sigma LX-Echospeed device
with a General Electric 1.5-T magnet (Waukesha, WI, USA).
After an overnight fast, the FSIVGTT was performed to deter-
mine insulin dynamics. A topical anaesthetic (EMLA cream;
AstraZeneca, Wilmington, DE, USA) was applied to the ante-
cubital area of both arms and an hour later a flexible intraven-
ous catheter was inserted into both arms. Two fasting blood
samples, at 
 
−
 
15 and 
 
−
 
5 min, were pooled for determination of
basal glucose and insulin values. At time zero, glucose (25%
dextrose; 0.3 g/kg of body weight) was administered intraven-
ously. Blood samples were then collected at the following time
points: 2, 4, 8, 19, 22, 30, 40, 50, 70, 100, 120 and 180 min
[21,22]. Insulin (0.02 U/kg of body weight; Humulin R—regular
unmodified insulin; Eli Lilly and Co., Indianapolis, IN, USA)
was injected intravenously at 20 min. Plasma was analysed for
glucose and insulin, and values were entered into the Minmod
Millennium 2003 computer program (version 5.16; Richard N.
Bergman, University of Southern California, Los Angeles, CA,
USA) for determination of insulin sensitivity (SI), the acute
insulin response (AIR 
 
=
 
 insulin area under the curve above basal
for the first 10 min of the FSIVGTT) and the disposition index
(DI 
 
=
 
 product of AIR and SI as a measure of pancreatic 
 
β
 
-cell
function) [22]. Blood samples from the FSIVGTT were centri-
fuged immediately to obtain plasma, and aliquots were frozen
at 
 
−
 
70
 
°
 
C until assayed. Glucose was assayed in duplicate on
a Yellow Springs Instrument 2700 Analyzer (Yellow Springs
Instrument, Yellow Springs, OH, USA) using the glucose oxidase
method. Insulin was assayed in duplicate using a specific human
insulin enzyme-linked immunosorbent assay kit from Linco
Research (St Charles, MO, USA). Plasma adiponectin was
measured using radioimmunoassay kits (Linco Research) with
an intra-assay coefficient of variation (CV) of 3.9% and an
interassay CV of 8.5%. For plasma leptin, radioimmunoassay
kits were used (Linco Research) with an intra-assay CV of 3.9%
and an interassay CV of 8.5%.
 
Statistical analysis
 
All data are reported as mean 
 
±
 
 
 
SE
 
. Statistical analyses were
performed using 
 
SPSS
 
 11 (SPSS Inc., Chicago, IL, USA). Baseline
characteristics of boys and girls were compared using Student’s
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t
 
-test or 
 
χ
 
2
 
 test. Variables not normally distributed (adiponectin,
leptin, SI, DI, AIR, total fat mass and lean body mass) were log
transformed before performing statistical analyses.
 
ANCOVA
 
 models were used to estimate the cumulative associa-
tion of family history of T2DM on plasma adiponectin and
leptin levels as dependent variables. Family history of T2DM was
modelled in two ways: first, a model was encoded including (i)
one parent’s family, either maternal or paternal family history, or
(ii) both, maternal and paternal family history. Next, to test
whether maternal and paternal family history of T2DM had
differential associations with plasma adiponectin and leptin,
another model was performed encoding (i) maternal family
history, (ii) paternal family history, and (iii) both maternal and
paternal family history. Maternal family history of T2DM is
defined as the presence of T2DM in a member of the mother’s
family (siblings and parents of the mother, or the mother herself).
Consistently, paternal family history of T2DM is defined as
presence of T2DM in the father’s family (siblings and parents of
the father, or the father himself). The same models were per-
formed for maternal or paternal diabetes without considering
other family members. All models were adjusted for gender,
Tanner stage, gestational diabetes of the mother while carrying
the participant, age, and percentage body fat and an interaction
term for Tanner stage and gender. Analyses were repeated with
and without inclusion of family history. 
 
R
 
2
 
 change is given
for the inclusion of family history. For leptin, models were per-
formed stratified by gender and adjusted as mentioned above.
In figures, estimated geometrical means are given stratified by
gender and Tanner stage after adjustment for gestational diabetes,
age, and percentage body fat.
 
Results
 
General characteristics of the study population are shown in
Table 1. Due to the inclusion criteria, all subjects had a family
history of T2DM. A maternal family history was reported by
47%, a paternal family history by 24% and a combination of
maternal and paternal family history by 29% of subjects.
Neither plasma leptin nor plasma adiponectin concentrations
were associated with the occurrence of gestational diabetes.
 
Leptin
 
Plasma leptin during puberty increased with age in girls but
not in boys (age 
 
×
 
 gender interaction, 
 
P 
 
=
 
 0.005, Fig. 1),
but no significant interaction for family history 
 
×
 
 gender was
observed.
In analyses adjusted for age, gender, gestational diabetes
and SI, a combined maternal and paternal family history of
T2DM was associated with higher plasma leptin (
 
P 
 
=
 
 0.044)
compared with a history of T2DM in only one parent’s family.
After additional adjustment for body fat, the association
between a combined maternal and paternal family history of
T2DM and plasma leptin was limited to Tanner stage 1 (
 
P 
 
=
 
0.004; 
 
P
 
 for interaction family history 
 
×
 
 tanner stage 
 
=
 
 0.022;
Fig. 2). No significant differences were observed between
maternal only and paternal only family history of T2DM. The
combination of maternal and paternal family history of
T2DM accounted for 4% (
 
P 
 
=
 
 0.003) of the variation in leptin
concentrations. The association between leptin concentrations
and combined family history of T2DM was not affected by
additional adjustment for visceral and subcutaneous fat. If
only the history of T2DM for first-degree relatives (mother
and father together) was included in the model, no association
with combined maternal and paternal family history was
observed, suggesting that general family history of T2DM is
important for the strength of this association compared with
family history in first-degree relatives alone.
 
Adiponectin
 
Adiponectin decreased with age in boys and girls (
 
r
 
 
 
=
 
 
 
−
 
0.231,
 
P 
 
=
 
 0.002, Fig. 1). Maternal and paternal family history of
Characteristics* Boys (n = 101) Girls (n = 74) P-value†
Age (years) 11.2 ± 0.2 11.1 ± 0.2 0.704
Body mass index (kg/m2) 28.2 ± 0.5 28.7 ± 0.6 0.435
Body mass index percentile 97.1 ± 0.3 97.4 ± 0.3 0.449
Total body fat (%) 37.6 ± 0.7 40.6 ± 0.6 0.002
Subcutaneous fat (cm2) 330 ± 15 357 ± 16 0.239
Visceral fat (cm2) 47 ± 2 50 ± 2 0.457
SI (×10–4/min/(μU/ml))‡ 2.17 ± 0.14 1.88 ± 0.15 0.104
Plasma leptin (μg/l) 23.2 ± 1.1 31.1 ± 1.5 0.533
Plasma adiponectin (mg/l) 10.2 ± 0.3 10.0 ± 0.4 0.220
Gestational diabetes (%) 19 23 0.570
Family history of Type 2 diabetes 0.375
Maternal only (%) 43 53
Paternal only (%) 24 23
Both (%) 33 24
*Data are mean ± SE, and %.
†Students t-tests and χ2 test used to compare differences between male and female patients.
‡SI, insulin sensitivity.
Table 1 Characteristics of the study cohort
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T2DM did not have a significant association with plasma
adiponectin levels (Fig. 3). Combined maternal and paternal
history of T2DM for first-degree relatives was also not associated
with plasma adiponectin levels. No gender or Tanner stage
interactions were observed.
 
Discussion
 
The major finding of the present study is that in overweight
Hispanic children a combined maternal and paternal family
history of T2DM is associated with higher leptin levels
compared with a family history of diabetes in the maternal
or paternal side alone. This association was independent of
adiposity. No such association was observed for plasma
adiponectin levels.
FIGURE 1 Serum leptin and adiponectin by age in overweight Hispanic 
boys (n = 101) and girls (n = 74).
FIGURE 2 Plasma leptin in overweight Hispanic children (n = 175) 
with maternal (mat) or paternal (pat) family history (FH) of Type 2 
diabetes. Data are estimate marginal means ± SE adjusted for age, body 
fat, gestational diabetes and insulin sensitivity. The interaction term for 
type of family history × Tanner stage, P < 0.022.
FIGURE 3 Plasma adiponectin in overweight Hispanic children 
(n = 175) with maternal (mat) or paternal (pat) family history (FH) of 
Type 2 diabetes. Data are estimate marginal means ± SE adjusted for age, 
body fat, gestational diabetes and insulin sensitivity. The interaction term 
for type of family history × Tanner stage, P < 0.427.
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Several studies have shown that a family history of T2DM
is associated with higher circulating leptin levels [11–13].
Recent data from the Quebec family study suggest that genetic
variation at the fat/fat mass and obesity associated (FTO)
locus contributes to the aetiology of obesity, insulin resistance
and increased plasma leptin levels [23]. Several polymor-
phisms in the leptin gene affect the receptor binding activity of
the protein [24] and secretion by adipose tissue. For example,
a polymorphism in the promoter region of the human leptin
gene has been associated with T2DM or impaired glucose
metabolism [25]. This polymorphism increases leptin protein
expression and secretion [26]. Another polymorphism, located
in an exonic region of the leptin gene, has been associated with
glucose homeostasis in response to exercise [27] and circulat-
ing leptin levels [28]. However, the association between the
polymorphism and leptin levels was not consistent in different
studies [29,30]. The association with a combined maternal
and paternal family history of T2DM supports the hypothesis
of a hereditary link between leptin and diabetes risk.
Other mechanisms explaining the association with a family
history of diabetes could be related to epigenetic effects that
are associated with both family history of T2DM and leptin
[31]. Fetal programming by maternal diabetes is unlikely to be
the cause of the association, because all results were adjusted
for gestational diabetes.
Hormonal changes during puberty result in gender-specific
differences in levels of leptin levels; oestrogen is known to
stimulate and testosterone to suppress leptin secretion [32].
Jansson 
 
et al.
 
 have shown that leptin levels were only higher
in male subjects with a family history of diabetes, but not in
female subjects, suggesting a pronounced gender difference in
the association between family history of diabetes and leptin
levels [11]. In our study, however, no significant interaction
was observed between gender and family history of T2DM,
suggesting that gender differences in leptin levels did not affect
the association between family history and leptin.
In the present study, a combined maternal and paternal
history of T2DM was associated with leptin independent of
the adjustment for adiposity. In analyses additionally adjusted
for adiposity, the association was stronger in participants
of Tanner stage 1 than in those in other Tanner stages. This
observation suggests that with progress of puberty other
adiposity-related changes outweigh the association between
family history of T2DM and leptin. In contrast, studies in
adults suggest that a family history of T2DM is associated with
higher concentrations of circulating leptin [11–13] independ-
ent of adiposity.
Several studies have also suggested an association between a
family history of T2DM and adiponectin levels resulting in
lower adiponectin levels in adult offspring of diabetic patients
compared with control subjects [14–18]. Several polymor-
phisms in the adiponectin gene have been associated with an
increased risk of diabetes. In the present study, we did not
observe any cumulative association between maternal and
paternal family history of T2DM and adiponectin levels as
observed for leptin. However, in the present study only subjects
with a family history of diabetes were included, and no com-
parison between presence and absence of family history could
be made.
The present study is limited by its cross-sectional design.
Therefore, we could not address the association of leptin and
adiponectin with the combined maternal and paternal family
history of diabetes on longitudinal changes in adiponectin and
leptin that may occur during puberty. We have recently shown
in a longitudinal study of the same cohort that the association
between a maternal family history of T2DM and insulin dynamics
becomes more pronounced during growth [33]. Longitudinal
studies on the association between family history and leptin
and adiponectin levels during growth will be necessary to demon-
strate whether this is similar for leptin and adiponectin.
In conclusion, a combination of a maternal and paternal
family history of T2DM is associated with higher leptin levels
independent of adiposity and SI in overweight Latino children
compared with a maternal or paternal family history alone.
No such association was observed for adiponectin.
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